COVID-19 and vaccination: myths vs science

VP Chavda, Y Chen, J Dave, ZS Chen… - Expert Review of …, 2022 - Taylor & Francis
Introduction Several vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) have been developed since the inception of the coronavirus disease 2019 …

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

O Sharma, AA Sultan, H Ding, CR Triggle - Frontiers in immunology, 2020 - frontiersin.org
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …

COVID-19 vaccines: concerns beyond protective efficacy and safety

CC Lai, IT Chen, CM Chao, PI Lee, WC Ko… - Expert review of …, 2021 - Taylor & Francis
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …

Looking to the future: is a universal coronavirus vaccine feasible?

VM Vashishtha, P Kumar - Expert Review of Vaccines, 2022 - Taylor & Francis
The Coronavirus Disease-2019 (COVID-19) pandemic has caused immeasurable human
suffering and economic harm. However, unprecedented global will and collaboration among …

[HTML][HTML] “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination

BR Bloom, GJ Nowak, W Orenstein - New England Journal of …, 2020 - Mass Medical Soc
“When Will We Have a Vaccine?” People inquiring about Covid-19 vaccines often want to
know when the public can be confident that available vaccines are safe and effective, when …

A narrative review of COVID-19 vaccines

B Eroglu, RF Nuwarda, I Ramzan, V Kayser - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic has shaken the world since early 2020 and its health, social,
economic, and societal negative impacts at the global scale have been catastrophic. Since …

[HTML][HTML] Review of COVID-19 vaccines approved in the United States of America for emergency use

D Vasireddy, P Atluri, SV Malayala… - Journal of clinical …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus
causing a global pandemic. Coronaviruses are a large family of single-stranded ribonucleic …

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations

J Sultana, G Mazzaglia, N Luxi… - Expert review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …

[HTML][HTML] A review on the advancements in the development of vaccines to combat coronavirus disease 2019

H Onyeaka, ZT Al-Sharify, MY Ghadhban… - Clinical and …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), the deadly disease caused by SARS-CoV-
2 (severe acute respiratory syndrome coronavirus 2) is a global pandemic that has severely …

Better strategies for coronavirus (COVID-19) vaccination

N Tzenios, M Chahine, M Tazanios - … of the Medical Academy and other …, 2023 - sjmas.com
The first case of COVID-19 a coronavirus disease, was reported in December 2019 in
Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …